Cardiovascular Effects of Smoking and Smoking Cessation: A 2024 Update

Mahfuzur Rahman; Mohammad Alatiqi; Mohammed Al Jarallah; Maryam Yousef Hussain; Abdul Monayem; Prashant Panduranga; Rajesh Rajan

doi:10.5334/gh.1399

Cardiovascular Effects of Smoking and Smoking Cessation: A 2024 Update

Volume 20 (2025): Issue 1

By: Mahfuzur Rahman , Mohammad Alatiqi, Mohammed Al Jarallah , Maryam Yousef Hussain , Abdul Monayem , Prashant Panduranga and Rajesh Rajan

Open Access

|Feb 2025

Abstract

Smoking is a significant risk factor for both acute and chronic cardiovascular diseases. These diseases contribute to approximately twenty percent of all-cause mortality. Research indicates that quitting smoking can substantially reduce or even reverse the harmful effects associated with smoking on cardiovascular health. Notably, these benefits can be observed in a relatively short period compared to the duration of smoking history. This article aims to provide data to understand the effects of smoking on the cardiovascular system locally as well as its effects as a pandemic globally and hence provide comprehensive strategies in the management of cardiovascular patients for smoking cessation.

References

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: A report from the American Heart Association. Circulation. 2018; 137(12):e67–e492. DOI: 10.1161/CIR.0000000000000558
Open DOI Search in Google Scholar Back to article
World Health Organization. WHO clinical treatment guideline for tobacco cessation in adults. World Health Organization; Jul 2024. 53 p. Available from: https://www.who.int/publications/i/item/9789240096431.
Search in Google Scholar Back to article
Dalmau R, Alanazi AM, Arora M, Banerjee A, Bianco E, Gaalema DE, et al. A complex interplay: Navigating the crossroads of tobacco use, cardiovascular disease, and the COVID-19 pandemic: A WHF policy brief. Global Heart. 2024; 19(1):55. DOI: 10.5334/gh.1334
Open DOI Search in Google Scholar Back to article
Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2009. DOI: 10.1201/9781420078848
Open DOI Search in Google Scholar Back to article
Pryor WA, Stone K. Oxidants in cigarette smoke: Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Annals of New York Academy of Sciences. 1993; 686(1993):12–28. DOI: 10.1111/j.1749-6632.1993.tb39148.x
Open DOI Search in Google Scholar Back to article
Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control. 2003; 12(4):424–430. DOI: 10.1136/tc.12.4.424
Open DOI Search in Google Scholar Back to article
Hoffmann D, Hoffmann I. Letters to the Editor – Tobacco smoke components. Beiträge zur Tabakforschung International. 1998; 18(1):49–52. DOI: 10.2478/cttr-2013-0668
Open DOI Search in Google Scholar Back to article
Soleimani F, Dobaradaran S, De-la-Torre GE, Schmidt TC, Saeedi R. Content of toxic components of cigarette, cigarette smoke vs Cigarette Butts: A comprehensive systematic review. Science of the Total Environment. 2022; 813(2022):152667. DOI: 10.1016/j.scitotenv.2021.152667
Open DOI Search in Google Scholar Back to article
Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American College of Cardiology. 2004; 43(10):1731–1737. DOI: 10.1016/j.jacc.2003.12.047
Open DOI Search in Google Scholar Back to article
Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis. 2001; 158(2):257–267. DOI: 10.1016/s0021-9150(01)00570-6
Open DOI Search in Google Scholar Back to article
Barua RS, Ambrose JA. Mechanisms of coronary thrombosis in cigarette smoke exposure. Arteriosclerosis, Thrombosis, and Vascular Biology. 2013; 33(7):1460–1467. DOI: 10.1161/ATVBAHA.112.300154
Open DOI Search in Google Scholar Back to article
Kjeldsen K, Thomsen HK, Astrup P. Effects of carbon monoxide on myocardium: Ultrastructural changes in rabbits after moderate, chronic exposure. Circulation Research. 1974; 34(3):339–348. DOI: 10.1161/01.res.34.3.339
Open DOI Search in Google Scholar Back to article
Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Cardiovascular effects of carbon monoxide and cigarette smoking. Journal of the American College of Cardiology. 2001; 38(6):1633–1638. DOI: 10.1016/s0735-1097(01)01616-3
Open DOI Search in Google Scholar Back to article
Sun YP, Zhu BQ, Browne AE, Sievers RE, Bekker JM, Chatterjee K, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation. 2001; 104(7):810–814. DOI: 10.1161/hc3301.092788
Open DOI Search in Google Scholar Back to article
Svrivastava SK, Barua RS, Saha DC, Eales-Reynolds LJ, DeVoe MC, Ambrose JA. Endogenous free radical generating sources are involved in smoking-mediated dysfunction of nitric oxide biosynthesis in human coronary artery endothelial cells: An in vitro demonstration, Journal of the American College of Cardiology. 2003; 41(6 Supplement 1):306A. DOI: 10.1016/S0735-1097(03)82432-4
Open DOI Search in Google Scholar Back to article
Kayyali US, Budhiraja R, Pennella CM, Cooray S, Lanzillo JJ, Chalkley R, et al. Upregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells. Toxicology and Applied Pharmacology. 2003; 188(1):59–68. DOI: 10.1016/s0041-008x(02)00076-5
Open DOI Search in Google Scholar Back to article
Meier BM, Shelley D. The fourth pillar of the Framework Convention on Tobacco Control: harm reduction and the international human right to health. Public Health Reports. 2006; 121(5):494–500. DOI: 10.1177/003335490612100503
Open DOI Search in Google Scholar Back to article
Hatsukami DK, Carroll DM. Tobacco harm reduction: Past history, current controversies and a proposed approach for the future. Preventive Medicine. 2020; 140:106099. DOI: 10.1016/j.ypmed.2020.106099
Open DOI Search in Google Scholar Back to article
Congress US. Family Smoking Prevention and Tobacco Control Act. In Congress US (Ed.) H R 1256 Vol Public Law. Washington, DC: U. S. Government Printing Office; 2009. pp. 111–131.
Search in Google Scholar Back to article
European Union. Manufacture, presentation and sale of tobacco products [Internet]. EUR-Lex [updated 2014 Jun; cited 2024 Sept]. Available from: https://eur-lex.europa.eu/EN/legal-content/summary/manufacture-presentation-and-sale-of-tobacco-products.html.
Search in Google Scholar Back to article
Lee PN, Fry JS, Hamling JS. Investigation into the risk of ultra-low tar cigarettes and lung cancer. Regulatory Toxicology and Pharmacology. 2017; 89(2017):112–117. DOI: 10.1016/j.yrtph.2017.07.023
Open DOI Search in Google Scholar Back to article
National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2001 Oct. Available from: https://cancercontrol.cancer.gov/sites/default/files/2020-08/m13_complete.pdf.
Search in Google Scholar Back to article
Pope CA 3rd, Burnett RT, Turner MC, Cohen A, Krewski D, Jerrett M, et al. Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: Shape of the exposure-response relationships. Environmental Health Perspectives. 2011; 119(11):1616–1621. DOI: 10.1289/ehp.1103639
Open DOI Search in Google Scholar Back to article
Lee PN. Tar level of cigarettes smoked and risk of smoking-related diseases. Inhalation Toxicology. 2018; 30(1):5–18. DOI: 10.1080/08958378.2018.1443174
Open DOI Search in Google Scholar Back to article
Hackshaw A, Morris JK, Boniface S, Tang JL, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: Meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018; 360:j5855. DOI: 10.113.6/bmj.j5855
Open DOI Search in Google Scholar Back to article
Black HR. Smoking and cardiovascular disease. In Laragh JH, Brenner BM (Eds.) Hypertension: Pathophysiology, Diagnosis and Management. 2nd edition. New York, NY: Raven Press Ltd.; 1995. pp. 2621–2647.
Search in Google Scholar Back to article
Clarkson TB, Weingand KW, Kaplan JR, Adams MR. Mechanisms of atherogenesis. Circulation. 1987; 76(1 part 2):20–28.
Search in Google Scholar Back to article
Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: An overview of molecular mechanisms. Current Vascular Pharmacology. 2007; 5(4):276–292. DOI: 10.2174/157016107782023406
Open DOI Search in Google Scholar Back to article
Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: An in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003; 107(18):2342–2347. DOI: 10.1161/01.CIR.0000066691.52789.BE
Open DOI Search in Google Scholar Back to article
Kayyali US, Budhiraja R, Pennella CM, Cooray S, Lanzillo JJ, Chalkley R, et al. Upregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells. Toxicology and Applied Pharmacology. 2003; 188(1):59–68. DOI: 10.1016/s0041-008X(02)00076-5
Open DOI Search in Google Scholar Back to article
Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2004; 24(6):1031–1036. DOI: 10.1161/01.ATV.0000127083.88549.58
Open DOI Search in Google Scholar Back to article
Suski JM, Lebiedzinska M, Bonora M, Pinton P, Duszynski J, Wieckowski MR. Relation between mitochondrial membrane potential and ROS formation. In Palmeira CM, Moreno AJ (Eds.) Mitochondrial Bioenergetics: Methods and Protocols. Totowa, NJ: Humana Press; 2012. pp. 183–205. DOI: 10.1007/978-1-61779-382-0_12
Open DOI Search in Google Scholar Back to article
Hansson GK, Libby P, Schönbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circulation Research. 2002; 91(4):281–291. DOI: 10.1161/01.res.0000029784.15893.10
Open DOI Search in Google Scholar Back to article
Ishida M, Sakai C, Ishida T. Role of DNA damage in the pathogenesis of atherosclerosis. Journal of Cardiology. 2022; 81(4):331–336. DOI: 10.1016/j.jjcc.2022.08.010
Open DOI Search in Google Scholar Back to article
Bouki KP, Katsafados MG, Chatzopoulos DN, Psychari SN, Toutouzas KP, Charalampopoulos AF, et al. Inflammatory markers and plaque morphology: An optical coherence tomography study. International Journal of Cardiology. 2012; 154(3):287–292. DOI: 10.1016/j.ijcard.2010.09.059
Open DOI Search in Google Scholar Back to article
Hawkins RI. Smoking, platelets and thrombosis. Nature. 1972; 236(5348):450–452. DOI: 10.1038/236450a0
Open DOI Search in Google Scholar Back to article
Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. The New England Journal of Medicine. 2023; 389(14):1273–1285. DOI: 10.1056/NEJMoa2206916
Open DOI Search in Google Scholar Back to article
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. Lancet. 2020; 395(10226):795–808. DOI: 10.1016/S0140-6736(19)32008-2
Open DOI Search in Google Scholar Back to article
Jaspers NEM, Blaha MJ, Matsushita K, van der Schouw Y, Wareham NJ, Khaw KT, et al. Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. European Heart Journal. 2020; 41(11):1190–1199. DOI: 10.1093/eurheartj/ehz239
Open DOI Search in Google Scholar Back to article
Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, et al. MORGAM (an international pooling of cardiovascular cohorts). International Journal of Epidemiology. 2005; 34(1):21–27. DOI: 10.1093/ije/dyh327
Open DOI Search in Google Scholar Back to article
Duncan MS, Freiberg MS, Greevy, RA Jr., Kundu S, Vasan RS, Tindle HA. Association of smoking cessation with subsequent risk of cardiovascular disease. JAMA. 2019; 322(7):642–650. DOI: 10.1001/jama.2019.10298
Open DOI Search in Google Scholar Back to article
Walicka M, Krysiński A, La Rosa GRM, Sun A, Campagna D, Di Ciaula A, et al. Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy. Diabetes & Metabolic Syndrome. 2024; 18(5):103044. DOI: 10.1016/j.dsx.2024.103044
Open DOI Search in Google Scholar Back to article
Jones MR, Barnoya J, Stranges S, Losonczy L, Navas-Acien A. Cardiovascular events following smoke-free legislations: An updated systematic review and meta-analysis. Current Environmental Health Reports. 2014; 1(3):239–249. DOI: 10.1007/s40572-014-0020-1
Open DOI Search in Google Scholar Back to article
Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011; 378(9799):1297–1305. DOI: ttps://doi.org/10.1016/S0140-6736(11)60781-2
Search in Google Scholar Back to article
Lan T, Palm KCA, Hoeben L, Benavente ED, Perry RN, Civelek M, et al. Tobacco smoking is associated with sex- and plaque-type specific upregulation of CRLF1 in atherosclerotic lesions. Atherosclerosis. 2024; 397(2024):118554. DOI: 10.1016/j.atherosclerosis.2024.118554
Open DOI Search in Google Scholar Back to article
Campesi I, Carru C, Zinellu A, Occhioni S, Sanna M, Palermo M, et al. Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans. American Journal of Translational Research. 2013; 5(5):497–509.
Search in Google Scholar Back to article
Tolstrup JS, Hvidtfeldt UA, Flachs EM, Spiegelman D, Heitmann BL, Bälter K, et al. Smoking and risk of coronary heart disease in younger, middle-aged, and older adults. American Journal of Public Health. 2014; 104(1):96–102. DOI: 10.2105/AJPH.2012.301091
Open DOI Search in Google Scholar Back to article
Dimitriadis K, Narkiewicz K, Leontsinis I, Konstantinidis D, Mihas C, Andrikou I, et al. Acute effects of electronic and tobacco cigarette smoking on sympathetic nerve activity and blood pressure in humans. International Journal of Environmental Research and Public Health. 2022; 19(6):3237. DOI: 10.3390/ijerph19063237
Open DOI Search in Google Scholar Back to article
Münzel T, Hahad O, Kuntic M, Keaney JF, Deanfield JE, Daiber A. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. European Heart Journal. 2020; 41(41):4057–4070. DOI: 10.1093/eurheartj/ehaa460
Open DOI Search in Google Scholar Back to article
Barkhurdar W, Hussain A, Saqlain M, Zahra R, Hussain I, Saqib M, et al. Smoking behaviour in post-acute myocardial infarction patients: cross-sectional study. Annals of Medicine and Surgery. 2024; 86(5):2531–2537. DOI: 10.1097/MS9.0000000000001333
Open DOI Search in Google Scholar Back to article
Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death & Disease. 2018; 9(2):171. DOI: 10.1038/s41419-017-0257-3
Open DOI Search in Google Scholar Back to article
Salehi N, Janjani P, Tadbiri H, Rozbahani M, Jalilian M. Effect of cigarette smoking on coronary arteries and pattern and severity of coronary artery disease: A review. The Journal of International Medical Research. 2021; 49(12):3000605211059893. DOI: 10.1177/03000605211059893
Open DOI Search in Google Scholar Back to article
Behrooz L, Abumoawad A, Rizvi SHM, Hamburg NM. A modern day perspective on smoking in peripheral artery disease. Frontiers in Cardiovascular Medicine. 2023; 10:1154708. DOI: 10.3389/fcvm.2023.1154708
Open DOI Search in Google Scholar Back to article
Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of abdominal aortic aneurysm: A systematic review and meta-analysis of prospective studies. Scientific Reports. 2018; 8(1):14786. DOI: 10.1038/s41598-018-32100-2
Open DOI Search in Google Scholar Back to article
Zieske AW, Takei H, Fallon KB, Strong JP. Smoking and atherosclerosis in youth. Atherosclerosis. 1999; 144(2):403–408. DOI: 10.1016/s0021-9150(98)00326-8
Open DOI Search in Google Scholar Back to article
Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023; 148(9):e9–e119. DOI: 10.1161/CIR.0000000000001168
Open DOI Search in Google Scholar Back to article
Gidding SS, Liu K, Colangelo LA, Cook NL, Goff DC, et al. Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation Cardiovascular Imaging. 2013; 6(5):769–775. DOI: 10.1161/CIRCIMAGING.112.000450
Open DOI Search in Google Scholar Back to article
N’Gbo N’Gbo Ikazabo R, Bier JC, Jamart J, Mostosi C, Mavroudakis N. Impact on quitting smoking of cognitive impairment in stroke patients. Journal of the Neurological Sciences. 2022; 439(2022):120296. DOI: 10.1016/j.jns.2022.120296
Open DOI Search in Google Scholar Back to article
Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nature Reviews Cardiology. 2017; 14(8):447–456. DOI: 10.1038/nrcardio.2017.36
Open DOI Search in Google Scholar Back to article
Mulder HA, Patterson JL, Halquist MS, Kosmider L, Turner JBM, Poklis JL, et al. The effect of electronic cigarette user modifications and e-liquid adulteration on the particle size profile of an aerosolized product. Scientific Reports. 2019; 9(1):10221. DOI: 10.1038/s41598-019-46387-2
Open DOI Search in Google Scholar Back to article
Gottlieb MA. Regulation of e-cigarettes in the United States and its role in a youth epidemic. Children. 2019; 6(3):40. DOI: 10.3390/children6030040d
Open DOI Search in Google Scholar Back to article
Cullen KA, Gentzke AS, Sawdey MD, Chang JT, Anic GM, Wang TW, et al. E-cigarette use among youth in the United States, 2019. JAMA. 2019; 322(21):2095–2103. DOI: 10.1001/jama.2019.18387
Open DOI Search in Google Scholar Back to article
Hammond D, Reid JL, Rynard VL, Fong GT, Cummings KM, McNeill A, et al. Prevalence of vaping and smoking among adolescents in Canada, England, and the United States: Repeat national cross sectional surveys. BMJ. 2019; 365:l2219. DOI: 10.1136/bmj.l2219
Open DOI Search in Google Scholar Back to article
Dai H, Leventhal AM. Prevalence of e-cigarette use among adults in the United States, 2014–2018. JAMA. 2019; 322(18):1824–1827. DOI: 10.1001/jama.2019.15331
Open DOI Search in Google Scholar Back to article
Skotsimara G, Antonopoulos AS, Oikonomou E, Siasos G, Ioakeimidis N, Tsalamandris S, et al. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis. European Journal of Preventative Cardiology. 2019; 26(11):1219–1228. DOI: 10.1177/2047487319832975
Open DOI Search in Google Scholar Back to article
Wang JB, Olgin JE, Nah G, Vittinghoff E, Cataldo JK, Pletcher MJ, et al. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study. PLoS One. 2018; 13(7):e0198681e0198681. DOI: 10.1371/journal.pone.0198681
Open DOI Search in Google Scholar Back to article
Ip M, Diamantakos E, Haptonstall K, Choroomi Y, Moheimani RS, Nguyen KH, et al. Tobacco and electronic cigarettes adversely impact ECG indexes of ventricular repolarization: Implication for sudden death risk. American Journal of Physiology Heart and Circulatory Physiology. 2020; 318(5):H1176–H1184. DOI: 10.1152/ajpheart.00738.2019
Open DOI Search in Google Scholar Back to article
Caporale A, Langham MC, Guo W, Johncola A, Chatterjee S, Wehrli FW. Acute effects of electronic cigarette aerosol inhalation on vascular function detected at quantitative MRI. Radiology. 2019; 293(1):97–106. DOI: 10.1148/radiol.2019190562
Open DOI Search in Google Scholar Back to article
Fetterman JL, Keith RJ, Palmisano JN, McGlasson KL, Weisbrod RM, Majid S, Bastin R, et al. Alterations in vascular function associated with the use of combustible and electronic cigarettes. Journal of the American Heart Association. 2020; 9(9):e014570. DOI: 10.1161/JAHA.119.014570
Open DOI Search in Google Scholar Back to article
Klaas FJW, Silja CT, Moritz M, Friedhelm S, Michael R, Klaus D, et al. E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: a randomized, double-blinded pilot study. Vascular Medicine. 2018; 23(5):419–425. DOI: 10.1177/1358863X18779694
Open DOI Search in Google Scholar Back to article
Espinoza-Derout J, Shao XM, Lao CJ, Hasan KM, Rivera JC, Jordan MC, et al. Electronic cigarette use and the risk of cardiovascular diseases. Frontiers in Cardiovascular Medicine. 2022; 9:879726. DOI: 10.3389/fcvm.2022.879726
Open DOI Search in Google Scholar Back to article
Kim SY, Sim S, Choi HG. Active, passive, and electronic cigarette smoking is associated with asthma in adolescents. Scientific Reports. 2017; 7(1):17789. DOI: 10.1038/s41598-017-17958-y
Open DOI Search in Google Scholar Back to article
de Borba AT, Jost RT, Gass R, Nedel FB, Cardoso DM, Pohl HH, et al. The influence of active and passive smoking on the cardiorespiratory fitness of adults. Multidisciplinary Respiratory Medicine. 2014; 9(1):34. DOI: 10.1186/2049-6958-9-34
Open DOI Search in Google Scholar Back to article
Hom S, Chen L, Wang T, Ghebrehiwet B, Yin W, Rubenstein DA. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets. 2016; 27(7):694–702. DOI: 10.3109/09537104.2016.1158403
Open DOI Search in Google Scholar Back to article
Rader F, Rashid M, Nguyen TT, Luong E, Kim A, Kim E, et al. E-cigarette use and subclinical cardiac effects. Circulation Research. 2020; 127(12):1566–1567. DOI: 10.1161/CIRCRESAHA.120.316683
Open DOI Search in Google Scholar Back to article
Sifat AE, Vaidya B, Kaisar MA, Cucullo L, Abbruscato TJ. Nicotine and electronic cigarette (e-cig) exposure decreases brain glucose utilization in ischemic stroke. Journal of Neurochemistry. 2018; 147(2):204–221. DOI: 10.1111/jnc.14561
Open DOI Search in Google Scholar Back to article
Raval AP. Nicotine addiction causes unique detrimental effects on women’s brains. Journal of Addictive Diseases. 2011; 30(2):149–158. DOI: 10.1080/10550887.2011.554782
Open DOI Search in Google Scholar Back to article
Moheimani RS, Bhetraratana M, Yin F, Peters KM, Gornbein J, Araujo JA, et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: Implications for cardiovascular risk. JAMA Cardiology. 2017; 2(3):278–284. DOI: 10.1001/jamacardio.2016.5303
Open DOI Search in Google Scholar Back to article
Basch CH, Mongiovi J, Hillyer GC, MacDonald Z, Basch CE. YouTube™ videos related to e-cigarette safety and related health risks: Implications for preventing and emerging epidemic. Public Health. 2016; 132:57–59. DOI: 10.1016/j.puhe.2015.12.003
Open DOI Search in Google Scholar Back to article
Laranjo L, Lanas F, Sun MC, Chen DA, Hynes L, Imran TF, et al. World Heart Federation roadmap for secondary prevention of cardiovascular disease: 2023 update. Global Heart. 2024; 19(1):8. DOI: 10.5334/gh.1278
Open DOI Search in Google Scholar Back to article
Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Rockville, MD: US Department of Health and Human Services; 2008 May. 276 p.
Search in Google Scholar Back to article
Rakel RE, Houston T. Nicotine addiction. In Rakel RE, Rakel DP (Eds.) Textbook of Family Medicine. Philadelphia, PA: Elsevier Health Sciences; 2011. pp. 1105–1122. DOI: 10.1016/B978-1-4377-1160-8.10050-8
Open DOI Search in Google Scholar Back to article
Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: A systematic review of the qualitative and quantitative literature. BMJ Open. 2014; 4(12):e006414. DOI: 10.1136/bmjopen-2014-006414
Open DOI Search in Google Scholar Back to article
Smokefree.gov. Cessation services data [Internet]. National Cancer Institute; [cited 2024 Dec 14]. Available from: https://smokefree.gov/about-us/cessation-services-data#:~:text=National%20Cessation%20Access%20Portals&text=The%20NNTCQ%20connects%20persons%20interested,%2D855%2DDEJELO%2DYA.
Search in Google Scholar Back to article
Centers for Disease Control and Prevention. Quitlines and other cessation support resources [Internet]. Centers for Disease Control and Prevention; [updated 2024 May 15; cited 2024 Dec 15]. Available from: https://www.cdc.gov/tobacco/hcp/patient-care/quitlines-and-other-resources.html.
Search in Google Scholar Back to article
National Health Service. NHS stop smoking services help you quit [Internet]. National Health Service; [updated 2022 Aug 17; cited 2024 Dec 15]. Available from: https://www.nhs.uk/live-well/quit-smoking/nhs-stop-smoking-services-help-you-quit/.
Search in Google Scholar Back to article
Nides M. Update on pharmacologic options for smoking cessation treatment. The American Journal of Medicine. 2008; 121(4):S20–S31. DOI: 10.1016/j.amjmed.2008.01.016
Open DOI Search in Google Scholar Back to article
Hays JT, McFadden DD, Ebbert JO. Pharmacologic agents for tobacco dependence treatment: 2011 update. Current Atherosclerosis Reports. 2012; 14(1):85–92. DOI: 10.1007/s11883-011-0211-2
Open DOI Search in Google Scholar Back to article
Eisenberg MJ, Filion KB, Yavin D, Belisle P, Mottillo S, Joseph L, et al. Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials. CMAJ. 2008; 179(2):135–144. DOI: 10.1503/cmaj.070256
Open DOI Search in Google Scholar Back to article
Stead L, Perera R, Bullen C, Mant D, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. The Cochrane Database of Systematic Reviews. 2012; 11:CD000146. DOI: 10.1002/14651858.CD000146.pub4
Open DOI Search in Google Scholar Back to article
Hughes J, Stead L, Cahill K, Lancaster T. Antidepressants for smoking cessation. The Cochrane Database of Systematic Reviews. 2007; 1:CD00031. DOI: 10.1002/14651858.CD000031.pub3
Open DOI Search in Google Scholar Back to article
Center for Drug Evaluation and Research. FDA Drug Safety Communication: FDA revises description of Mental Health [Internet]. U.S. Food and Drug Administration; 2018 [cited 2025 Feb 15]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-revises-description-mental-health-side-effects-stop-smoking.
Search in Google Scholar Back to article
Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES trial. Journal of Clinical Psychopharmacology. 2019; 39(2):108–116. DOI: 10.1097/JCP.0000000000001015
Open DOI Search in Google Scholar Back to article
Cahill K, Lindson-Hawley N, Thomas K, Fanshawe T, Lancaster T. Nicotine receptor partial agonists for smoking cessation. The Cochrane Database Systematic Reviews. 2016; 5:CD006103. DOI: 10.1002/14651858.CD006103.pub7
Open DOI Search in Google Scholar Back to article
Center for Drug Evaluation and Research. Safety Review update of Chantix [Internet]. U.S. Food and Drug Administration; 2017 [cited 2025 Feb 15]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-safety-review-update-chantix-varenicline-and-risk-cardiovascular.
Search in Google Scholar Back to article
US Food and Drug Administration. FDA drug safety communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease [Internet]. US Food and Drug Administration; [updated 2016 Mar 2; cited 2017 Jul 5]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-chantix-varenicline-may-increase-risk-certain-cardiovascular-adverse.
Search in Google Scholar Back to article
Dehghani P, Habib B, Windle SB, Roy N, Old W, Grondin FR, et al. Smokers and postcessation weight gain after acute coronary syndrome. Journal of the American Heart Association. 2017; 6(4):e004785. DOI: 10.1161/JAHA.116.004785
Open DOI Search in Google Scholar Back to article
Gourlay S, Stead L, Benowitz N. Clonidine for smoking cessation. The Cochrane Database of Systematic Reviews. 2004; 3:CD000058. DOI: 10.1002/14651858.CD000058.pub2
Open DOI Search in Google Scholar Back to article
Hughes JR, Stead LF, Lancaster T. Nortriptyline for smoking cessation: A review. Nicotine & Tobacco Research. 2005; 7(4):491–499. DOI: 10.1080/14622200500185298
Open DOI Search in Google Scholar Back to article
Tinghino B, Cardellicchio S, Corso F, Cresci C, Pittelli V, Principe R, et al. Cytisine for smoking cessation: A 40-day treatment with an induction period. Tobacco Prevention & Cessation. 2024; 10. DOI: 10.18332/tpc/187556
Open DOI Search in Google Scholar Back to article
Blanch P, Freixa-Pamais R. When are you going to quit smoking? European Society of Cardiology. 2021; 20(6). Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-20/when-are-you-going-to-quit-smoking.
Search in Google Scholar Back to article
European Network for Smoking and Tobacco Prevention. European smoking cessation guidelines and quality standards [Internet]. European Network for Smoking and Tobacco Prevention; [cited 2024 Sept 11]. Available from: https://ensp.network/european-smoking-cessation-guidelines-and-quality-standards/.
Search in Google Scholar Back to article
Rigotti NA, Benowitz NL, Prochaska J, Leischow S, Nides M, Blumenstein B, et al. Cytisinicline for smoking cessation: A randomized clinical trial. JAMA. 2023; 330(2):152–160. DOI: 10.1001/jama.2023.10042
Open DOI Search in Google Scholar Back to article
Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. The Cochrane Database of Systematic Reviews. 2019; 4:CD013308. DOI: 10.1002/14651858.CD013308
Open DOI Search in Google Scholar Back to article
Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, et al. Antidepressants for smoking cessation. The Cochrane Database of Systematic Reviews. 2023; 5(5):CD000031. DOI: 10.1002/14651858.CD000031.pub6
Open DOI Search in Google Scholar Back to article
Cinciripini PM, Green CE, Shete S, Minnix JA, Robinson JD, Cui Y, et al. Smoking cessation after initial treatment failure with varenicline or nicotine replacement: A randomized clinical trial. JAMA. 2024; 331(20):1722–1731. DOI: 10.1001/jama.2024.4183
Open DOI Search in Google Scholar Back to article
Fiore MC. Tobacco use and dependence: A 2011 update of treatments [Internet]. University of Wisconsin School of Medicine and Public Health [updated 2012 Jan 25]. Available from: https://www.medscape.org/viewarticle/757167.
Search in Google Scholar Back to article
Ockene I, Salmoirago-Blotcher E. Varenicline for smoking cessation in patients with coronary heart disease. Circulation. 2010; 121(2):188–90. DOI: 10.1161/CIRCULATIONAHA.109.915546
Open DOI Search in Google Scholar Back to article
Dinno A, Glantz S. Clean indoor air laws immediately reduce heart attacks. Preventive Medicine. 2007; 45(1):9–11. DOI: 10.1016/j.ypmed.2007.03.013
Open DOI Search in Google Scholar Back to article
Barua R, Rigotti N, Benowitz N, Cummings KM, Jazayeri MA, Morris PB, et al. ACC expert consensus decision pathway on tobacco cessation treatment: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. Journal of the American College of Cardiology. 2018; 72(25):3332–3365. DOI: 10.1016/j.jacc.2018.10.027
Open DOI Search in Google Scholar Back to article
Müezzinler A, Mons U, Gellert C, Schöttker B, Jansen E, Kee F, et al. Smoking and all-cause mortality in older adults: Results from the CHANCES consortium. American Journal of Preventative Medicine. 2015; 49(5):e53–e63. DOI: 10.1016/j.amepre.2015.04.004
Open DOI Search in Google Scholar Back to article
Bolliger CT, Zellweger JP, Danielsson T, van Biljon X, Robidou A, Westin A, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine & Tobacco Research. 2002; 4(4):433–439. DOI: 10.1080/1462220021000018380.96
Open DOI Search in Google Scholar Back to article
Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: Meta-analysis. BMJ. 2012; 345:e4439. DOI: 10.1136/bmj.e4439
Open DOI Search in Google Scholar Back to article
Wada H, Ura S, Satoh-Asahara N, Kitaoka S, Mashiba S, Akao M, et al. α1-antitrypsin low-density-lipoprotein serves as a marker of smoking-specific oxidative stress. Journal of Atherosclerosis and Thrombosis. 2012(1);19:47–58. DOI: 10.5551/jat.9035
Open DOI Search in Google Scholar Back to article
Komiyama M, Wada H, Ura S, Yamakage H, Satoh-Asahara N, Shimada S, et al. The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin low-density lipoprotein. Heart and Vessels. 2015; 30(6):734–739. DOI: 10.1007/s00380-014-0549-9
Open DOI Search in Google Scholar Back to article
Komiyama M, Shimada S, Wada H, Yamakage H, Satoh-Asahara N, Shimatsu A, et al. Time-dependent changes of atherosclerotic LDL complexes after smoking cessation. Journal of Atherosclerosis and Thrombosis. 2016; 23(11):1270–1275. DOI: 10.5551/jat.34280
Open DOI Search in Google Scholar Back to article
Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, et al. Smoking cessation, weight change, type 2 diabetes, and mortality. The New England Journal of Medicine. 2018; 379:623–32. DOI: 10.1056/NEJMoa1803626
Open DOI Search in Google Scholar Back to article
Bush T, Lovejoy J, Javitz H, Torres AJ, Wassum K, Tan MM, et al. Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial. BMC Public Health. 2018; 18:678–690. DOI: 10.1186/s12889-018-5574-7
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.5334/gh.1399 | Journal eISSN: 2211-8179

Journal RSS Feed

Language: English

Submitted on: Sep 24, 2024

Accepted on: Jan 23, 2025

Published on: Feb 19, 2025

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Smoking,

Cardiovascular diseases,

electronic cigarettes

© 2025 Mahfuzur Rahman, Mohammad Alatiqi, Mohammed Al Jarallah, Maryam Yousef Hussain, Abdul Monayem, Prashant Panduranga, Rajesh Rajan, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 20 (2025): Issue 1